Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × Tadalafil × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma 2 Sexual Dysfunction, Physiological 1 Pyridoxine-dependent epilepsy 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Liver Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Adenocarcinoma 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡